StockTipsArenaBeta

BUY Gland Pharma Limited — ICICI Securities

BUYGland Pharma Limited

byICICI SecuritiesHorizon: NA (inferred 1 year)22 May 2026via Institutional / Brokerage Research

Entry₹2,334Inferred
Target₹2,645
Total upside +13.32% (call closed)
Stop lossNot given
Exit₹2,64510 Aug 2026, 12:08 pm
Target hit+13.32%0.00%upside left
Follow ICICI Securities for new calls(68% target hit, 1025 closed calls)Get alertsWatch GLAND for new buy/sell callsGet alertsSee 6 active Long-term calls on GLANDSee 36 active Long-term picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 10 Aug 2026
4 supporting3 neutral1 opposing
Supports the BUY call (4)

Gland Pharma has entered into a strategic Contract Development and Manufacturing Organization (CDMO) partnership with an unnamed global pharmaceutical company. This collaboration is expected to enhanc

BSE · Company Update·9 Aug · yesterday

(opens in new tab)

Gland Pharma Ltd has entered into a strategic collaboration with Neuland Laboratories for the manufacturing of sterile Active Pharmaceutical Ingredients (APIs).

BSE · Company Update·5 Aug · 4d ago

(opens in new tab)

Gland Pharma Ltd has received approval for its Suggamadex Injection.

BSE · Company Update·29 Jul · 2w ago

(opens in new tab)

3 advisors have active short-term BUY calls on this stock

Advisor consensus · adjacent horizon·24 Jul · 2w ago

Neutral / worth noting (3)

Corporate Actions This Week: Indus Towers, PTC India, Gland Pharma, HAL, HPCL, REC | Full List

NewsNdtv-Profit·9 Aug · yesterday

(opens in new tab)
Weighs against the BUY call (1)

Gland Pharma, Lupin, Dr Reddy's: All Nifty Pharma Stocks In Red After Trump's Drug Tariff Plan

NewsNdtv-Profit·22 Jul · 3w ago

(opens in new tab)

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

StockTipsArena© 2026 · NSE equities only · Not investment advicePublic beta · data is auto-aggregated from public sources and may contain errors — verify before acting.